Codex4SMEs - Companion Diagnostics expedited for SMEs


Project Summary

The Interreg project Codex4SMEs (Companion diagnostics expedited for small and medium-sized businesses) project plans to improve healthcare by enhanced adoption of Personalized Medicine in North-West Europe. The objective is to establish a network, which supports SMEs along the value chain of Companion diagnostics (Cdx) development.

Companion diagnostics (Cdx) are an indispensable tool for optimum application of Personalized Medicine: they allow tests to determine the molecular causes of a disease before treatment has started. However, thus far the development of companion diagnostics has been highly time-consuming and costly, so at present it is only used in the context of very few treatments.

Codex4SMEs will establish a transnational network of nine partners and two sub-partners from seven countries and expedite the development of the SMEs’ products in the field of Cdx. There is a need to improve SMEs‘ innovative capabilities and raise both international competitiveness and the impact of North-West Europe SMEs in this global market as the USA are far ahead - Codex4SMEs will directly address this challenge.

 

Benefits for SMEs

  • Access to:
    • Sample access service
    • biomarker validation service
    • knowledge transfer service of biomarker/biobanking
    • ecosystems from 11 partners
    • transnational roadshow to venture and large pharma companies
    • business model and expert access service for business growth and scaling
  • Tailored support dependent from the product TRL levels of the SMEs

 

Partners

Lead Partner: BioRegio STERN Management GmbH, DE

Project Partners:

  • University of Leicester (and subpartner) UK
  • BOM Holding BV, NL
  • WestBIC, IE
  • Innovation Quarter (and subpartner) NL
  • Medicen Paris Region, FR
  • Integrated BioBank of Luxembourg, LU
  • Biobank Graz at the Medical University of Graz, AT
  • CÙRAM Centre for Research in Medical Devices, IE

Associated Partner:

EATRIS European Infrastructure for Translational Medicine, NL

 


Save the date: Pitch & Win - the pitch learning programm

SME’s get the opportunity to pitch their project in front of investors in Palais Brongniart, Paris, in partnership with EIT Health Summit 2019. The Pitch & Win offer is a blended learning program, which aims to help SME’s to pitch on December 4th.

Pitch & Win - the pitch learning programme


Webinar and double session event ahead

Save the date for Codex4SME's next events: Webinar with speaker Justin Stindt on reimbursement and market access - September 5th, 2019 and Double session event in Galway - September 18th, 2019

Webinar - market access and reimbursement

Project Partners

  • University of Leicester

    1 University Road
    Leicester
    LE1 7RH
    United Kingdom

    View partner details

  • BOM Holding BV

    15 Goirlese Weg
    Tilburg
    5026
    Netherlands

    View partner details

  • Innovation and Management Centre Limited T/A WestBIC

    Galway Technology Centre Mervue Business Park
    Galway
    H91 E2W5
    Ireland

    View partner details

  • InnovationQuarter

    32 Prinses Margrietplantsoen
    Den Haag
    2595
    Netherlands

    View partner details

  • Medicen Paris Region

    3-5 Impasse Reille
    Paris
    75014
    France

    View partner details

  • Integrated BioBank of Luxembourg

    6 Rue Nicolas Ernest Barblé
    Luxembourg
    L-1210
    Luxembourg

    View partner details

  • Biobank Graz @ Medizinische Universität Graz

    2 Auenbruggerplatz
    Graz
    A-8036
    Austria

    View partner details

  • CÚRAM Centre for Research in Medical Devices

    Biomedical Sciences National University of Ireland Galway
    Galway
    H91 TK33
    Ireland

    View partner details

  • BioRegio STERN Managment GmbH

    10 Friedrichstrasse
    Stuttgart
    70174
    Germany

    View partner details

Lead partner

Organisation Contact name Address Email Website
BioRegio STERN Managment GmbH Margot Jehle 10 Friedrichstrasse
Stuttgart
70174
Germany
jehle@bioregio-stern.de www.bioregio-stern.de
Name Contact Name Email Country
University of Leicester Carl M Edwards ce133@le.ac.uk United Kingdom
BOM Holding BV Maria Hein rhein@bom.nl Netherlands
Innovation and Management Centre Limited T/A WestBIC Eunan Cunningham ecunningham@westbic.ie Ireland
InnovationQuarter Lonneke Baas Lonneke.baas@innovationquarter.nl Netherlands
Medicen Paris Region Olivier Fontaine ofontaine@medicen.org France
Integrated BioBank of Luxembourg Christelle Bahlawane Codex4SMEs@ibbl.lu Luxembourg
Biobank Graz @ Medizinische Universität Graz Karine Sargsyan codex4smes@medunigraz.at Austria
CÚRAM Centre for Research in Medical Devices John Cunningham jcunningham@nuigalway.ie Ireland

Events


Biobank course: How to build a biobank?

, Biobank Graz, AT

This interactive 3-day-course has been designed for all those who are involved in setting up a new biobank, who look to collaborate with a biobank or research institute, who face the challenges of a growing biobank or who try to overcome the challenges of maintaining a large biobank. The format of this course is a mixture of presentations and discussion sessions allowing participants to learn from the expert advice and the specific experience of their peers. Bring your questions with you for discussion!
Read More

Diagnostics-4-Future Conference 2019

, Konstanz, Germany

With more than 150 attendees from differnet European countries, the „Diagnostics-4-Future Conference“ is THE international meeting-place for users and providers in diagnostics and adjacent fields. Based on questions in medical care, clinics and laboratories, innovative solutions for new diagnostics are discussed including research and development. The focus is also on solutions for rural areas (point-of-care). Organiser is the international competence network for diagnostics DiagNET that is funded by the Interreg V-Programme.
Read More


News


Atriva Therapeutics Receives EU Award for Biomarker Validation

Posted on

Atriva Therapeutics GmbH, a biopharmaceutical company pioneering the development of host-targeting antiviral therapies, today announced that they have received the Biomarker Validation Award as part of the European Interreg Project Codex4SME. A total of four award winners will receive a grant of approximately 100,000 Euros each, in the form of laboratory services by the Integrated Biobank of Luxembourg. Read More

Exclusive access to biobank service

Posted on

Four companies from Germany, France and the Netherlands have been presented with the Biomarker Validation Award as part of Codex4SMEs. The European project aims to establish a transnational network to accelerate the development of companion diagnostics along the entire value chain of small and medium-sized enterprises. The award is endowed with approximately EUR 100,000, which is handed over in the form of laboratory services. The chosen companies can now have their respective biomarkers validated by the Integrated Biobank of Luxembourg – in other words, have them tested to assess their reliability with regard to their relevant indication. Read More

Presentation of the webinar with Tom Miller

Posted on

Finding capital to fund your (companion) diagnostics SME: The Venture Capital perspective. On 28 May, a webinar with Tom Miller in the frame of the Interreg NWE project 'Codex4SMEs' took place. Tom Miller is founder of Greybird Ventures and is dedicated to invest in companies that can help to eliminate "trial and error" medicine with high-specifity diagnostics and generate value for patients, providers, developers of therapies, and those who pay for healthcare. Read More

Save the date: Webinar with Tom Miller (Greybird Ventures), May 28th

Posted on

Finding capital to fund your (companion) diagnostics SME: The Venture Capital perspective. The Interreg NWE project 'Codex4SMEs' proudly announces a webinar with Tom Miller, founder of Greybird Ventures, who is dedicated to invest in companies that can help to eliminate "trial and error" medicine with high-specifity diagnostics and generate value for patients, providers, developers of therapies, and those who pay for healthcare. Read More

Idris Oncology one of first companies to receive free human tissue through Codex4SME’s

Posted on

The Leiden based biotechnology firm Idris Oncology is one of the three SME’s in Europe to receive human tissue through the Codex4SME’s consortium, in order to help them progress their diagnostic product towards clinical application. Interreg project Codex4SME's supports entrepreneurs in Life Sciences & Health sector in obtaining human tissue from biobanks. The application process for tissue can be very lingering and complicated. Read More


The Codex4SMEs project offers a tailored support scheme covering 100 % of the costs by the project.

 

Following services are available within the project:

 

  • Knowledge Transfer (in biomarker & biobanking topics) and Sample Access delivered by the Biobank Graz
  • Biomarker Validation Service for early and late stage delivered by the Integrated Biobank of Luxembourg

Knowledge Transfer and Sample Access services will be available within continuously open calls after official start of application process.

For the Biomarker Validation Service a so called “Biomarker Validation Award” will be launched where potential interested SMEs can apply within two calls.

 

For interested SMEs, the guidelines and the application documents are available for download.

Sample access & knowledge transfer (Biobank Graz)

  • continously

 

Biomarker validation service (Integrated Biobank of Luxembourg)

  • Service will be provided by an award
  • First call period: Oktober 15th, 2018 till December 14th, 2018
  • Second call period: February 18th, 2019 until April 19th, 2019

 

For further Information please visit the tab "Calls"

CALL OPENING

 

Potential interested SMEs have the opportunity to apply for these services continously within an open call by filling in the relevant application forms listed in the tab "support scheme". Please note that the project will offer a limited number of sample access and knowledge transfer services in total!

 

 Sample access & knowledge transfer (Biobank Graz)

  • continously

 

Biomarker validation service (Integrated Biobank of Luxembourg)

  • Service will be provided by an award
  • First call period: Oktober 15th, 2018 until December 14th, 2018
  • Second call period: February 18th, 2019 until April 19th, 2019

 

The Advisory Board acts as an observing body. They provide insights and recommendations on different topics in the framework of Cdx to support the project.

These are the members:

  • Andreas Baur, BioLAGO e.V.
  • Dr. Michael Steinwand, BioLAGO e.V.
  • Miranda Wijnstekers, Head of Economy & Innovation
  • Dick de Jager, BOM Holding
  • Sylvain Lehmann, French society of Clinical Biology
  • Philippe Manivet, French society of Clinical Biology
  • Prof. Dr. Kurt Zatloukal, Medical University of Graz
  • Prof. Dr. Berthold Huppertz, Medical University of Graz
  • Florence Bietrix, EATRIS- ERIC
  • Eric Steinfelder, BBMRI- ERIC
  • Diarmuid Cahalan, Metabolomic Diagnostics
  • Dave Mead, PhD, Medilink East Midlands

The Expert Group are involved in both services provided by the biobanks - the biomarker validation service (IBBL) and the sample access service (BBG).

They evaluate the application forms and give recommendation to the Codex4SMEs partner consortium.

These are the members:

  • Marie Souleau, European Patent Attorney
  • Patrice Debre, Pitié- Salpêtrière Hospital, INSERM

The map gives an overview of companies which are active in the field of companion diagnostics in the partner regions. When you klick at one selected company, further information like the main activities or the contact datails are mentioned.

Be part of the Codex4SMEs network, contact your regional partner and get an entry on the map.

 

Benefit from the Codex4SMEs projekt and get tailored support depending on your product TRL level. Furthermore you get access to:

  • Sample access service
  • biomarker validation service
  • knowledge transfer service of biomarker/biobanking
  • ecosystems from 11 partners
  • transnational roadshow to venture and large pharma companies
  • business model and expert access service for business growth and scaling

Share this

Tweet Share